Biochemistry, Genetics and Molecular Biology
Peroxiredoxin
100%
Thioredoxin
79%
Osteoclastogenesis
74%
Hydrogen Peroxide
73%
Cysteine
48%
Disulfide
46%
Cancer Cell
45%
Oxidoreductase
36%
Cysteine Sulfinic Acid
31%
Thiol
30%
Active Site
29%
Transcription Factor Nrf2
28%
Reductase
27%
Complement Factor B
27%
Tumor Necrosis Factor
26%
Gene Expression Data
24%
Osteoclast
24%
Adenosine Triphosphate
24%
Light Chain
22%
Dynein
22%
Signal Transduction
21%
Peroxiredoxin 1
20%
Osteolysis
19%
Bone Development
18%
Candida Albicans
18%
Oxidative Stress
18%
Kinase
18%
Phosphotransferase
17%
Lactoperoxidase
17%
Peroxidase
16%
AP-1 Transcription Factor
16%
Overall Survival
15%
Sulfinic Acid
15%
Transcription Factor NFAT
14%
Lipopolysaccharide
14%
Synapsin I
14%
N-Terminus
13%
Actin
12%
Promoter Region
12%
Phosphatase
12%
Mitochondrion
12%
Gene Signature
11%
RANKL
11%
Enzymatic Hydrolysis
10%
Oxidation Reduction Potential
10%
Acetylcysteine
9%
S100A10
9%
Glyceraldehyde 3-Phosphate Dehydrogenase
9%
Tumor Progression
9%
Epidermal Growth Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
40%
Peroxiredoxin
36%
Hydrogen Peroxide
36%
Thioredoxin
35%
Reactive Oxygen Metabolite
35%
Transcription Factor Nrf2
29%
Antioxidant
26%
Dynein Adenosine Triphosphatase
23%
Liver Cell Carcinoma
23%
Thiol
21%
Lactoperoxidase
20%
Peroxidase
20%
Nuclear Factor
18%
Alternative Complement Pathway C3 C5 Convertase
16%
Receptor
15%
Tumor Necrosis Factor
14%
Lipopolysaccharide
14%
Phosphotransferase
14%
Transcription Factor AP 1
13%
Cysteine
13%
Bone Disease
12%
Hydroperoxide
12%
Tumor Suppressor Protein
12%
Amino Acid
11%
Interleukin 1
11%
Cysteine Sulfinic Acid
10%
Osteoclast Differentiation Factor
10%
Transcription Factor NFAT
10%
Inflammation
9%
Tumor Growth
9%
Hyperlipidemia
9%
Resistin
9%
Flunarizine
9%
Mammalian Target of Rapamycin Complex 1
9%
Peroxiredoxin 1
9%
Synapsin I
9%
Recurrent Disease
9%
Adipocytokine
9%
Euphorbia
9%
Benzydamine
9%
Acetylcysteine
6%
Mouse Model
6%
Disulfide
6%
Antioxidant Capacity
6%
Oxidoreductase
6%
Atherosclerosis
5%
Glutathione
5%
Neoplasm
5%
Medicine and Dentistry
Cancer Cell
28%
Peroxiredoxin
20%
Hydrogen Peroxide
19%
Oxidative Stress
19%
Osteoclastogenesis
18%
Antioxidant
13%
Homeostasis
11%
Cancer Therapy
9%
Adjuvant Chemotherapy
9%
Recurrent Disease
9%
Tumor Progression
9%
Adipocytokine
9%
Hepatocellular Carcinoma
9%
Osteoclast Differentiation Factor
9%
The Cancer Genome Atlas
9%
Peroxiredoxin 1
9%
Hyperlipidemia
9%
Bone Development
9%
Transcription Factor Nrf2
9%
Abdominal Cancer
9%
Antioxidant Capacity
8%
Lung Adenocarcinoma
8%
Acetylcysteine
7%
Acute Toxicity
6%
Programmed Cell Death
6%
Gene Expression Profiling
5%
Chromosomal Instability
5%
Cell Death
5%
Gene Expression
5%
Overall Survival
5%
